| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 157,408 shares worth roughly $644K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | Khan Najat49 | Chief R&D Commercial Officer | Sell | 36,599 | $5.52 | $202,172.88 | -5.2% | -25.4% | -44.0% | |
| Aug 11, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 618,175 | $5.28 | $3,263,964.00 | - | -14.7% | -36.7% | |
| Mar 27, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 138,574 | $6.04 | $836,986.96 | -11.0% | -13.6% | -50.8% | |
| Mar 6, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $6.48 | $259,000.00 | -3.1% | -21.3% | -44.7% | |
| Feb 6, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $7.90 | $316,000.00 | -3.0% | -42.1% | -45.0% | |
| Jan 10, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $7.18 | $287,200.00 | -5.2% | -34.4% | -32.3% | |
| Dec 5, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $7.14 | $285,600.00 | -5.2% | -0.2% | -28.5% | |
| Nov 14, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 40,000 | $7.55 | $301,800.00 | -5.0% | +20.7% | -40.1% | |
| Nov 13, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 30,000 | $7.65 | $229,504.50 | -2.0% | +4.6% | -40.8% | |
| Nov 12, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $7.64 | $87,457.37 | -0.2% | +0.9% | -38.7% |